7th European Conference on Schizophrenia Research

8 OVERVIEW | Friday, 27 September 2019 Room Time Plenary 2nd Floor Harvard 1st Floor Stanford 1st Floor Princeton 1st Floor Foyer Ground Floor 08:30 – 10:00 S-10 Pathobiology, measurement and treatment of motor signs in psychosis S-11 Schizophrenia and cancer. The role of microRNAs S-12 5 years of PRONIA: What have we learned? O-03 Neuroimaging Registration Counter Opening Hours: 08:00 – 18:00 Coffee Break 10:30 – 12:00 D-01 ‘Precision‘ or ‘Personalized‘ psychiatry: Different terms – same content? S-13 Dopaminergic dysfunction and its functional implica- tions S-14 Visual percep- tual dysfunction in schizophrenia: Psychophysical, neurobiological and computational perspectives O-04 Neuropsychology 12:15 – 13:00 PL-02 Inflammation in psychotic disorders: Triggers and targets 13:00 - 14:30 Lunch Break 13:30 – 14:30 Guided Poster Tours P-05 to P-08 Foyer/Event Area, Ground Floor 14:30 – 16:00 SA-02 Psychosocial treatment S-15 Update on the newly published S3 guideline of schizophrenia S-16 Basic symptoms in research and clinic: Past, presence and future S-17 The impact of social adversity on psychosis-like experiences along the normal to clinical continuum – a biological and behavioural analysis of social reactivity Coffee Break 16:30 – 18:00 S-18 The aberrant Salience-hypothesis and the clinical high-risk state of schizophrenia S-19 Targeting patients‘ specific brain net- works for psychotic symptoms: Moving towards precision and personalized rTMS S-20 Novel approaches and methods to schizophrenia spec- trum neurobiology: Translation and precision psychiatry O-05 Treatment and mental health care PL - Plenary Lecture SA -State-of-the-Art Lecture S - Symposium O -Oral Presentation D -Discussion